NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anxuyuan Biotechnology (Shenzhen) Co., Ltd.

Anxuyuan Biotechnology (Shenzhen) Co., Ltd.

Private
ShenzhenHealthcare & Life Scienceshttps://axbio.cn/

Last Round

Series B

Jun 20, 2022

Est. Valuation

$347.5M

Total Funding Raised

$100M

Company Overview

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. is a biotechnology company that develops semiconductor-based tools for genomic analysis, including nanopore sequencing platforms, Bio-CMOS chip design, and electrochemical sensing for molecular diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Semiconductors, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

nanopore sequencingmicrofluidicsBio-CMOSmolecular diagnosticslab-on-a-chipgenomic sequencingbasecallingpoint-of-care diagnosticsclinical testing equipmentbioinformaticspathogen detectionnucleic acid extractionportable sequencerdeep learning diagnosticsbenchtop sequencer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 20, 2022
Series A ExtensionOct 31, 2021
AngelDec 1, 2017

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Investors

Notable investors and investment history

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. investors
InvestorRounds
SDIC Fund ManagementSeries B
Widi CapitalSeries B
Kaitai CapitalSeries A Extension
MSA CapitalSeries A Extension
CBC GroupSeries B
Yunfeng CapitalSeries B
5Y CapitalSeries B, Series A Extension

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anxuyuan Biotechnology (Shenzhen) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anxuyuan Biotechnology (Shenzhen) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range1
Year Founded2017
Last FundingJun 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.